Industry reports
Editor highlights

Search inside this page

Free Market Research Guides to Download

Biological Therapy Analysis & Statistics, January 2014 (p4)

You might be interested in: stem cell, cell therapy, tissue engineering, more »

» Purchase Premium Reports

91-120 of about 400 reports
GENova Biotherapeutics, Inc. (GVBP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

GENova Biotherapeutics, Inc. (GVBP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • January 2014
  • by Global Data

Summary GENova Biotherapeutics, Inc. (GENova) is a publicly traded biotechnological drug development company, engaged in the identifying, evaluating and acquiring drugs for treatment of oncological and ...

  • Industries : Biological Therapy
  • Countries : United States
CellSeed Inc. (7776) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

CellSeed Inc. (7776) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • January 2014
  • by Global Data

Summary CellSeed Inc. (Cell Seed) is a biotechnology company, based in Japan. The company develops and provides innovative solutions for tissue-engineering through novel cell harvest methods. It products ...

  • Industries : Biological Therapy
  • Countries : Japan, Australia, World
Chemokine Therapeutics Corp. (CTI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Chemokine Therapeutics Corp. (CTI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • January 2014
  • by Global Data

Summary Chemokine Therapeutics Corp. (Chemokine Therapeutics) is a publicly held biotechnology company. It is engaged in the discovery and develops peptide analogs of chemokines for cancer treatment and ...

  • Industries : Biological Therapy
  • Countries : Canada, United Kingdom
CHA Bio & Diostech Co., Ltd. (085660) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

CHA Bio & Diostech Co., Ltd. (085660) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • January 2014
  • by Global Data

Summary CHA Bio & Diostech Co., Ltd. (CHA Bio & Diostech) is a bio technology company, based in South Korea. It develops advance biomedicine through applied life science and technology. The company's products ...

  • Industries : Biological Therapy
  • Countries : South Korea
Cell Medica Limited - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Cell Medica Limited - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • January 2014
  • by Global Data

Summary Cell Medica Limited (Cell Medica) is a biotechnology company. It manufactures and distributes cellular immunotherapy antigen-specific T cells products for the treatment of infectious disease and ...

  • Industries : Biological Therapy
Cyntellect, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Cyntellect, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • January 2014
  • by Global Data

Summary Cyntellect, Inc. (Cyntellect) is a life science company based in the US. The company provides standards for advancing the fields of cell analysis. Its products include celigo and c-lect consumables. ...

  • Industries : Biological Therapy
  • Countries : United States
CMC Biologics AS - Pharmaceuticals & Healthcare - Deals and Alliances Profile

CMC Biologics AS - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • January 2014
  • by Global Data

Summary CMC Biologics A/S (CMC Biologics) is a contract biopharmaceutical manufacturing and development company. It provides manufacturing services for DNA, active pharmaceutical ingredient (APIs), and ...

  • Industries : Biological Therapy
arGEN-X BV - Pharmaceuticals & Healthcare - Deals and Alliances Profile

arGEN-X BV - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • January 2014
  • by Global Data

Summary arGEN-X BV (arGEN-X) is a clinical stage biopharmaceutical company. The company discovers and develops human therapeutic antibodies. It operates through drug discovery and manufacturing, research ...

  • Industries : Biological Therapy
Cellartis AB - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Cellartis AB - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • January 2014
  • by Global Data

Summary Cellartis AB (Cellartis) is a biotechnology company. The company provides pluripotent stem cells and human embryonic stem cells, and technology for drug discovery research, toxicity testing and ...

  • Industries : Biological Therapy
  • Countries : United States
Imiquimod: Pipeline™ Selector: Patent Report

Imiquimod: Pipeline™ Selector: Patent Report

  • $ 220
  • Industry report
  • March 2014
  • by GenericsWeb

0

  • Industries : Biological Therapy
Tissue Therapies Ltd

Tissue Therapies Ltd

  • $ 55
  • Company report
  • April 2014
  • by Wright Investors' Service

A textual analysis of the financial results for Tissue Therapies Ltd compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses ...

  • Industries : Biological Therapy
Zhongyuan Union Stem Cell Bio-Engineering Corp

Zhongyuan Union Stem Cell Bio-Engineering Corp

  • $ 55
  • Company report
  • April 2014
  • by Wright Investors' Service

A textual analysis of the financial results for Zhongyuan Union Stem Cell Bio-Engineering Corp compared to selected competitors. Also included are quantitative analyses of the company's financial statements, ...

  • Industries : Biological Therapy
Ecomic Co.,Ltd

Ecomic Co.,Ltd

  • $ 55
  • Company report
  • April 2014
  • by Wright Investors' Service

A textual analysis of the financial results for Ecomic Co.,Ltd compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses ...

  • Industries : Biological Therapy
  • Countries : Japan
International Stem Cell Corporation

International Stem Cell Corporation

  • $ 55
  • Company report
  • April 2014
  • by Wright Investors' Service

A textual analysis of the financial results for International Stem Cell Corporation compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ...

  • Industries : Biological Therapy
Japan Tissue Engineering Company Limited

Japan Tissue Engineering Company Limited

  • $ 55
  • Company report
  • April 2014
  • by Wright Investors' Service

A textual analysis of the financial results for Japan Tissue Engineering Company Limited compared to selected competitors. Also included are quantitative analyses of the company's financial statements, ...

  • Industries : Biological Therapy
  • Countries : Japan
Stemgent, Inc. SWOT Analysis, Strategy, Revenues and Profits

Stemgent, Inc. SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • January 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
MacroGenics, Inc. (MGNX) - Financial and Strategic SWOT Analysis Review

MacroGenics, Inc. (MGNX) - Financial and Strategic SWOT Analysis Review

  • $ 125
  • Company report
  • January 2014
  • by Global Data

MacroGenics, Inc. (MGNX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData ...

  • Industries : Biological Therapy
Benitec Biopharma Limited (BLT) - Financial and Strategic SWOT Analysis Review

Benitec Biopharma Limited (BLT) - Financial and Strategic SWOT Analysis Review

  • $ 125
  • Company report
  • January 2014
  • by Global Data

Benitec Biopharma Limited (BLT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled ...

  • Industries : Biological Therapy
  • Countries : France
Mice Model Market - by Type [Inbred, Knockout, Conditioned], Technology [Microinjection, Embryonic Stem Cell], Disease [Oncology, Immunology, CNS], Service [Breeding, Cryopreservation, Quarantine] & Care Products [Cages, Bedding, Feed] - Forecasts to 2018

Mice Model Market - by Type [Inbred, Knockout, Conditioned], Technology [Microinjection, Embryonic Stem Cell], Disease [Oncology, Immunology, CNS], Service [Breeding, Cryopreservation, Quarantine] & Care Products [Cages, Bedding, Feed] - Forecasts to 2018

  • $ 4 650
  • Industry report
  • January 2014
  • by MarketsandMarkets

Mice Model Market - by Type [Inbred, Knockout, Conditioned], Technology [Microinjection, Embryonic Stem Cell], Disease [Oncology, Immunology, CNS], Service [Breeding, Cryopreservation, Quarantine] & Care ...

  • Industries : Biological Therapy
  • Countries : World
Global Mesenchymal Stem Cells Industry

Global Mesenchymal Stem Cells Industry

  • $ 4 950
  • Industry report
  • January 2014
  • by Global Industry Analysts

This report analyzes the worldwide markets for Mesenchymal Stem Cells (MSCs) in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest ...

  • Industries : Biological Therapy
Global Neural Control Trends Industry

Global Neural Control Trends Industry

  • $ 950
  • Industry report
  • January 2014
  • by Global Industry Analysts

The report outlines the creation of 'cyborg', a partially machine (robot) and partially human organism represents an artificial conversion of a human to a machine, through an appropriate computer-human ...

  • Industries : Biological Therapy
  • Countries : World
Global Cancer Stem Cell Trends Industry

Global Cancer Stem Cell Trends Industry

  • $ 1 450
  • Industry report
  • January 2014
  • by Global Industry Analysts

The report illustrates on the growing market for Cancer Stem Cells (CSCs) in the US and Europe The major factors stimulating the growth of the market are the rising affliction of diseases such as cance ...

  • Industries : Biological Therapy
  • Countries : United States
Global Single Cell Omics Trends Industry

Global Single Cell Omics Trends Industry

  • $ 950
  • Industry report
  • January 2014
  • by Global Industry Analysts

Single Cell Omics, a cutting edge technology, mainly integrates advanced technology with biology for a variety of single cell applications. The technology helps to study single cells at a much deeper level ...

  • Industries : Biological Therapy
  • Countries : World, United States
Stemedica Cell Technologies, Inc. - Product Pipeline Review - 2013

Stemedica Cell Technologies, Inc. - Product Pipeline Review - 2013

  • $ 1 500
  • Company report
  • December 2013
  • by Global Markets Direct

Stemedica Cell Technologies, Inc. - Product Pipeline Review - 2013 Summary Global Market Direct's pharmaceuticals report, “Stemedica Cell Technologies, Inc. - Product Pipeline Review - 2013” provides ...

  • Industries : Biological Therapy
  • Countries : World
Bioheart, Inc. - Product Pipeline Review - 2013

Bioheart, Inc. - Product Pipeline Review - 2013

  • $ 1 500
  • Company report
  • December 2013
  • by Global Markets Direct

Bioheart, Inc. - Product Pipeline Review - 2013 Summary Global Market Direct's pharmaceuticals report, “Bioheart, Inc. - Product Pipeline Review - 2013” provides data on the Bioheart, Inc.'s research ...

  • Industries : Biological Therapy
  • Countries : World
Life Technologies Corporation - Strategy and SWOT Report

Life Technologies Corporation - Strategy and SWOT Report

  • $ 175
  • Company report
  • December 2013
  • by MarketLine

Life Technologies Corporation - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service ...

  • Industries : Biological Therapy
  • Countries : United States
John Daniel Holdings Limited (JDH) - Financial and Strategic SWOT Analysis Review

John Daniel Holdings Limited (JDH) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2013
  • by Global Data

Summary John Daniel Holdings Limited (JDHL) is a South African venture capital holding company. The company invests in companies, which are niche and strategic in nature in the healthcare, biotechnology ...

  • Industries : Biological Therapy
  • Countries : South Africa
Stem Cell Sciences Plc (STEM) - Strategic SWOT Analysis Review

Stem Cell Sciences Plc (STEM) - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2013
  • by Global Data

Summary This comprehensive SWOT profile of Stem Cell Sciences Plc provides you with an in-depth strategic analysis of the company's businesses and operations. The profile will give you a clear and an unbiased ...

  • Industries : Biological Therapy
Physician Views: Oncologist reaction to Roche's Gazyva - US approval and new late-stage data versus Rituxan

Physician Views: Oncologist reaction to Roche's Gazyva - US approval and new late-stage data versus Rituxan

  • $ 645
  • Industry report
  • November 2013
  • by Firstword Pharma

Scope Roche's efforts to enhance its dominance of the haematological cancer market received notable momentum last week when the company gained FDA approval for Gazyva as a first-line treatment for chronic ...

  • Industries : Biological Therapy
  • Countries : United States
Bone Regeneration - Pipeline Review, H2 2013

Bone Regeneration - Pipeline Review, H2 2013

  • $ 2 000
  • Company report
  • October 2013
  • by Global Markets Direct

Bone Regeneration - Pipeline Review, H2 2013 Summary Global Markets Direct's, 'Bone Regeneration - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report ...

  • Industries : Biological Therapy
  • Countries : World

» View Public Reports

About 900 reports

Cell Culture Business (cell culture, cell therapy) in Thailand and The United States

  • Industry report
  • March 2014
  • 7 pages
  • by Research Paper

... cultured cells selected for high production of secondary metabolites (dicosmo and misawa, 1995). One way to increase the production level of secondary metabolites is by elicitation, which ...


» Read our Company Profiles

35 Companies

GlaxoSmithKline P.L.C.

United States

Bioheart Inc.

United States

StemCells Inc.

United States

Geron Corp.

United States

Osiris Therapeutics Inc.

United States

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.